IGM Biosciences, Inc.

NASDAQ:IGMS

1.39 (USD) • At close March 11, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017
Assets:
Current Assets:
Cash & Cash Equivalents 26.495112.52121.231133.334241.0835.8911.8870.432
Short Term Investments 157.292225.157305.93196.208125.189188.74300
Cash and Short Term Investments 183.787337.677427.162229.542366.269236.6071.8870.432
Net Receivables 000000.0350.0350
Inventory 00000-11.97300
Other Current Assets 9.8339.9221.32911.20514.0066.4310.4850.223
Total Current Assets 193.62347.597438.421240.747373.272231.12.4070.655
Non-Current Assets:
Property, Plant & Equipment, Net 71.03374.00573.07556.34434.81218.0191.4720.677
Goodwill 00000000
Intangible Assets 00000000
Goodwill and Intangible Assets 00000000
Long Term Investments 0000011.9730.10.05
Tax Assets 00000000
Other Non-Current Assets 1.0591.8092.0031.0360.5480.25800.008
Total Non-Current Assets 72.09275.81475.07857.3835.3630.251.5720.735
Total Assets 265.712423.411513.499298.127408.632261.353.9791.39
Liabilities & Equity:
Current Liabilities:
Account Payables 0.9831.3262.5125.5847.9243.0870.1640.225
Short Term Debt 7.1215.83411.6326.645.3344.9668.3240
Tax Payables 00000000.128
Deferred Revenue 2.6513.777148.9310003.690.116
Other Current Liabilities 26.88331.54427.80515.5563.9820.8223.5910.507
Total Current Liabilities 37.63842.48144.68527.7817.248.8758.890.976
Non-Current Liabilities:
Long Term Debt 38.06534.67235.35625.4399.57712.24400
Deferred Revenue Non-Current 0143.024146.19500000.125
Deferred Tax Liabilities Non-Current 00-146.19500000
Other Non-Current Liabilities 141.8370000060.91740.792
Total Non-Current Liabilities 179.902177.696181.55125.4399.57712.24460.91740.917
Total Liabilities 217.54220.177226.23653.21926.81721.11969.80741.893
Equity:
Preferred Stock 00000261.3560.91740.783
Common Stock 0.3420.5860.4310.3250.3190.3040.0040.004
Retained Earnings -1,017.037-821.242-574.826-353.724-188.56-107.205-64.072-41.361
Accumulated Other Comprehensive Income/Loss 0.1590.151-0.701-0.0660.0260.043-0.667-0.389
Other Total Stockholders Equity 1,064.7081,023.739862.359598.373570.0385.73962.78675.044
Total Shareholders Equity 48.172203.234-574.826-353.724-188.56-107.205-65.828-40.503
Total Equity 48.172203.234-574.826-353.724-188.56-107.205-65.828-40.503
Total Liabilities & Shareholders Equity 265.712423.411-348.59-300.505-161.743-86.0863.9791.39